Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells
- DOI
- 10.1186/s13287-026-04994-7
- Published
- 2026-03-29
- Container
- Stem Cell Research & Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13287-026-04994-7,
title = {Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells},
author = {Takahiro Aoki and Midori Kobayashi and Momoko Okoshi and Munechika Yamaguchi and Hiroko Okura and Satoko Sasaki and Yoshie Sasako and Sachiko Kira and Yun-Hsuan Chang and Nayuta Yakushiji-Kaminatsui and Jafar Sharif and Masashi Matsuda and Masahiro Kiuchi and Kiyoshi Hirahara and Motoko Y. Kimura and Shinichiro Motohashi and Haruhiko Koseki},
year = {2026},
journal = {Stem Cell Research \& Therapy},
doi = {10.1186/s13287-026-04994-7},
url = {https://doi.org/10.1186/s13287-026-04994-7}
}RIS
TY - JOUR TI - Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells AU - Takahiro Aoki AU - Midori Kobayashi AU - Momoko Okoshi AU - Munechika Yamaguchi AU - Hiroko Okura AU - Satoko Sasaki AU - Yoshie Sasako AU - Sachiko Kira AU - Yun-Hsuan Chang AU - Nayuta Yakushiji-Kaminatsui AU - Jafar Sharif AU - Masashi Matsuda AU - Masahiro Kiuchi AU - Kiyoshi Hirahara AU - Motoko Y. Kimura AU - Shinichiro Motohashi AU - Haruhiko Koseki PY - 2026 JO - Stem Cell Research & Therapy DO - 10.1186/s13287-026-04994-7 UR - https://doi.org/10.1186/s13287-026-04994-7 ER -
APA
Aoki, T., Kobayashi, M., Okoshi, M., Yamaguchi, M., Okura, H., Sasaki, S., Sasako, Y., Kira, S., Chang, Y., Yakushiji-Kaminatsui, N., Sharif, J., Matsuda, M., Kiuchi, M., Hirahara, K., Kimura, M. Y., Motohashi, S., & Koseki, H. (2026). Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-026-04994-7
Source records
- crossref · retrieved 2026-09-26T17:37:44.652Z